Professor, Digestive Diseases/Gastroenterology; Physician, Hepatology, UCLA School of Medicine
General Surgery
Dr. Myron J. Tong, MD
|
|
Give Review
Myron Tong practices General Surgery. He studied medicine at University of California San Francisco School of Medicine. University of California San Francisco School of Medicine is a top medical college. University of California San Francisco School of Medicine is ranked 3/3 in Research/PrimaryCare. Myron Tong is also published. He has 53 publications published. The lastest publication: "Timing of Antiviral Therapy in Candidates for Liver Transplant for Hepatitis C and Hepatocellular Carcinoma.' Myron Tong accepts Medicare payments and is registered with Medicare.gov.
Publications
- Durability of Hepatitis B e Antigen Seroconversion in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir.
- Probiotics are Helpful in Hepatic Encephalopathy: A Meta-Analysis of Randomized Trials.
- A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
- The impact of obesity on patient survival in liver transplant recipients: a meta-analysis.
- Evaluation of alpha-fetoprotein in detecting hepatocellular carcinoma recurrence after radiofrequency ablation.
- Impact of coffee on liver diseases: a systematic review.
- Improvement in liver histology among Asian patients with chronic hepatitis B after long-term treatment with entecavir.
- Complete tumor encapsulation on magnetic resonance imaging: A potentially useful imaging biomarker for better survival in solitary large hepatocellular carcinoma.
- Hepatitis B "inactive carriers": Clinical course and outcomes.
- Trends in viral hepatitis cost-effectiveness studies.
- MRI detection of intratumoral fat in hepatocellular carcinoma: potential biomarker for a more favorable prognosis.
- Improved understanding of risk factors could help to reduce the incidence of hepatocellular carcinoma.
- An Algorithm for Risk Assessment and Intervention of Mother to Child Transmission of Hepatitis B Virus.
- The management of chronic hepatitis B in Asian Americans.
- Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma: a 24-year experience in a single center.
- A proposed, evidence-based approach to the treatment of chronic Hepatitis B.
- CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis.
- Clinical roundtable monograph. Integrating recent data in managing adverse events in the treatment of hepatocellular carcinoma.
- Chronic hepatitis B and hepatocellular carcinoma.
- Timing of hepatitis C antiviral therapy in patients with advanced liver disease: a decision analysis model.
- Surveillance for hepatocellular carcinoma improves survival in Asian-American patients with hepatitis B: results from a community-based clinic.
- Survival in Asian Americans after treatments for hepatocellular carcinoma: a seven-year experience at UCLA.
- Endoscopic treatment of postorthotopic liver transplantation anastomotic biliary strictures with maximal stent therapy (with video).
- Comparison of different immunoprophylaxis regimens after liver transplantation with hepatitis B core antibody-positive donors: a systematic review.
- A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection.
- Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen-positive patients after liver transplantation.
- Is the search for a single comprehensive staging system for hepatocellular carcinoma an elusive one?
- Development of hepatocellular carcinoma after seroclearance of hepatitis B surface antigen.
- Factors associated with progression to hepatocellular carcinoma and to death from liver complications in patients with HBsAg-positive cirrhosis.
- Endoscopic treatment with multiple stents for post-liver-transplantation nonanastomotic biliary strictures.
- Acetaminophen hepatotoxicity and acute liver failure.
- Oral antibiotic prophylaxis reduces spontaneous bacterial peritonitis occurrence and improves short-term survival in cirrhosis: a meta-analysis.
- Sustained hepatitis B e antigen seroconversion in patients with chronic hepatitis B after adefovir dipivoxil treatment: analysis of precore and basal core promoter mut...
- Treatment recommendations for chronic hepatitis B: an evaluation of current guidelines based on a natural history study in the United States.
- Medical therapies to extend survival in hepatocellular carcinoma.
- Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators.
- Hepatitis B prophylaxis in patients undergoing chemotherapy for lymphoma: a decision analysis model.
- Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA.
- Employment and quality of life in liver transplant recipients.
- Anemia in liver transplant recipients undergoing antiviral treatment for recurrent hepatitis C.
- Chronic viral hepatitis and hepatocellular carcinoma.
- The emerging importance of chronic hepatitis C infection in Asian Americans.
- Acinetobacter infection: what was the true impact during the Vietnam conflict?
- Management of patients with cirrhosis in Southern California: results of a practitioner survey.
- Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation.
- Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver.
- MELD fails to measure quality of life in liver transplant candidates.
- Treatment of patients with chronic hepatitis B with adefovir dipivoxil.
- Hepatocellular Carcinoma: A Clinician's Prospective.
- Hepatocellular Carcinoma in Asian Americans.
- The Impact of Hepatitis B Infection in Asian Americans.
- Timing of Antiviral Therapy in Candidates for Liver Transplant for Hepatitis C and Hepatocellular Carcinoma.
Doctors Specialties
- Internal Medicine
- General Surgery
Accepted Insurances
Education
-
University of Southern California - LAC+USC Medical Center -
University of California San Francisco School of Medicine
Hospital
-
Ronald Reagan UCLA Medical Center -
Huntington Memorial Hospital
Drug Facts
| NPI NUMBER | 1407839681 | |
| NPPES Provider LastName | TONG | |
| NPPES Provider FirstName | MYRON | |
| NPPES Provider ZIPCode | 900950001 | |
| NPPES Provider State | CA | |
| Specialty Description | General Surgery | |
| Total Claim Count | 1073.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1407839681 |
| Last Name Of The Provider | TONG |
| First Name Of The Provider | MYRON |
| View All |
Similar Doctors
|
|
Dr. Chelsea L. Collins, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elie M. Gindi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey W. Brettler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William N. Ricketts, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Valentine T. Ifeacho, MD |
|
|
Dr. Humberto D. Martinez, MD |
|
|
Dr. Amy C. McClune, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kanika A. Bowen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James M. Tatum, MD |